Kodiak Sciences
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KOD and other ETFs, options, and stocks.About KOD
Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD.
KOD Key Statistics
Stock Snapshot
The current Kodiak Sciences(KOD) stock price is $41.35, with a market capitalization of 2.59B. The stock trades at a price-to-earnings (P/E) ratio of -9.86.
During the trading session on 2026-08-15, Kodiak Sciences(KOD) shares reached a daily high of $41.97 and a low of $36.35. At a current price of $41.35, the stock is +13.8% higher than the low and still -1.5% under the high.
Trading volume for Kodiak Sciences(KOD) stock has reached 738.9K, versus its average volume of 596.16K.
The stock's 52-week range extends from a low of $8.29 to a high of $47.84.
The stock's 52-week range extends from a low of $8.29 to a high of $47.84.
KOD News
...
Kodiak Sciences has completed enrollment of the first 300-patient cohort in its Phase 3 PEAK trial of KSI-101 for macular edema secondary to inflammation, advan...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.